4.5 Article

A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark: the C-Free-South project

Journal

BMC INFECTIOUS DISEASES
Volume 22, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12879-022-07196-7

Keywords

Hepatitis C virus; Elimination; Epidemiology; Interventions; Testing; Treatment

Funding

  1. Gilead Science [ISR-DK-18-10469]
  2. Region of Southern Denmark
  3. University of Southern Denmark
  4. Abbvie

Ask authors/readers for more resources

Denmark has signed the WHO strategy to eliminate hepatitis C virus (HCV) and in the absence of a national strategy for elimination, a local action plan was developed in the Region of Southern Denmark (RSD) with the aim to diagnose 90% of HCV-infected persons and treat 80% of those diagnosed by 2025. The strategy was developed by reviewing Danish data on HCV epidemiology and drug use to identify key populations for screening, linkage to care, and treatment.
Denmark has signed the WHO strategy to eliminate hepatitis C virus (HCV). In the absence of a national strategy for elimination, a local action plan was developed in the Region of Southern Denmark (RSD). The aim of the strategy is to diagnose 90% of HCV-infected persons and treat 80% of those diagnosed by 2025. The strategy was developed by reviewing Danish data on HCV epidemiology and drug use to identify key populations for screening, linkage to care, and treatment. Based on available published data from 2016, an estimated 3028 persons in the RSD were HCV-RNA positive (population prevalence 0.21%). Of these, 1002 were attending clinical care, 1299 were diagnosed but not in clinical care, and 727 were undiagnosed. Three different interventions targeting the HCV-infected population and two interventions for HCV surveillance are planned to achieve elimination. The C-Free-South strategy aims to eliminate HCV in our region by identifying (90%) and treating (80%) of infected persons by the end of 2025, 5 years earlier than the WHO elimination target date.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available